advertisement
International Journal of Pharmaceutics 52
Showing records 1 to 25 | Display only abstracts in International Journal of Pharmaceutics from IGR 20-2107823 An update of nano-based drug delivery systems for cannabinoids: Biopharmaceutical aspects & therapeutic applications
Lazzarotto Rebelatto ER; Rauber GS; Caon T
International Journal of Pharmaceutics 2023; 635: 122727 (IGR: 23-4)
104901 3D printing in Ophthalmology: From medical implants to personalised medicine
Tan G; Ioannou N; Mathew E; Tagalakis AD; Lamprou DA; Yu-Wai-Man C
International Journal of Pharmaceutics 2022; 625: 122094 (IGR: 23-2)
98382 Development and optimization of Riluzole-loaded biodegradable nanoparticles incorporated in a mucoadhesive in situ gel for the posterior eye segment
Esteruelas G
International Journal of Pharmaceutics 2022; 612: 121379 (IGR: 22-4)
99024 The dose-dependent effect of a stabilized cannabidiol nanoemulsion on ocular surface inflammation and intraocular pressure
Rebibo L; Frušić-Zlotkin M
International Journal of Pharmaceutics 2022; 617: 121627 (IGR: 22-4)
98382 Development and optimization of Riluzole-loaded biodegradable nanoparticles incorporated in a mucoadhesive in situ gel for the posterior eye segment
Halbaut L; García-Torra V
International Journal of Pharmaceutics 2022; 612: 121379 (IGR: 22-4)
99024 The dose-dependent effect of a stabilized cannabidiol nanoemulsion on ocular surface inflammation and intraocular pressure
Ofri R; Nassar T
International Journal of Pharmaceutics 2022; 617: 121627 (IGR: 22-4)
98382 Development and optimization of Riluzole-loaded biodegradable nanoparticles incorporated in a mucoadhesive in situ gel for the posterior eye segment
Espina M; Cano A
International Journal of Pharmaceutics 2022; 612: 121379 (IGR: 22-4)
99024 The dose-dependent effect of a stabilized cannabidiol nanoemulsion on ocular surface inflammation and intraocular pressure
Benita S
International Journal of Pharmaceutics 2022; 617: 121627 (IGR: 22-4)
98382 Development and optimization of Riluzole-loaded biodegradable nanoparticles incorporated in a mucoadhesive in situ gel for the posterior eye segment
Ettcheto M; Camins A; Souto EB; Luisa García M; Sánchez-López E
International Journal of Pharmaceutics 2022; 612: 121379 (IGR: 22-4)
95325 Reduced deliquescency of isosorbide by cocrystallization and mechanisms for hygroscopicity
Watanabe T
International Journal of Pharmaceutics 2021; 607: 120959 (IGR: 22-2)
95468 Development, characterization, and ex vivo evaluation of an insert for the ocular administration of progesterone
Alambiaga-Caravaca AM
International Journal of Pharmaceutics 2021; 606: 120921 (IGR: 22-2)
94436 Cyclodextrin-based formulation of carbonic anhydrase inhibitors for ocular delivery - A review
Jansook P
International Journal of Pharmaceutics 2021; 606: 120955 (IGR: 22-2)
95325 Reduced deliquescency of isosorbide by cocrystallization and mechanisms for hygroscopicity
Ito M
International Journal of Pharmaceutics 2021; 607: 120959 (IGR: 22-2)
94436 Cyclodextrin-based formulation of carbonic anhydrase inhibitors for ocular delivery - A review
Hnin HM
International Journal of Pharmaceutics 2021; 606: 120955 (IGR: 22-2)
95468 Development, characterization, and ex vivo evaluation of an insert for the ocular administration of progesterone
Domenech-Monsell IM
International Journal of Pharmaceutics 2021; 606: 120921 (IGR: 22-2)
94436 Cyclodextrin-based formulation of carbonic anhydrase inhibitors for ocular delivery - A review
Loftsson T
International Journal of Pharmaceutics 2021; 606: 120955 (IGR: 22-2)
95468 Development, characterization, and ex vivo evaluation of an insert for the ocular administration of progesterone
Sebastián-Morelló M
International Journal of Pharmaceutics 2021; 606: 120921 (IGR: 22-2)
95325 Reduced deliquescency of isosorbide by cocrystallization and mechanisms for hygroscopicity
Suzuki H
International Journal of Pharmaceutics 2021; 607: 120959 (IGR: 22-2)
95468 Development, characterization, and ex vivo evaluation of an insert for the ocular administration of progesterone
Calatayud-Pascual MA
International Journal of Pharmaceutics 2021; 606: 120921 (IGR: 22-2)
94436 Cyclodextrin-based formulation of carbonic anhydrase inhibitors for ocular delivery - A review
Stefánsson E
International Journal of Pharmaceutics 2021; 606: 120955 (IGR: 22-2)
95325 Reduced deliquescency of isosorbide by cocrystallization and mechanisms for hygroscopicity
Terada K; Noguchi S
International Journal of Pharmaceutics 2021; 607: 120959 (IGR: 22-2)
95468 Development, characterization, and ex vivo evaluation of an insert for the ocular administration of progesterone
Merino V; Rodilla V; López-Castellano A
International Journal of Pharmaceutics 2021; 606: 120921 (IGR: 22-2)
92288 Betaxolol-loaded niosomes integrated within pH-sensitive in situ forming gel for management of glaucoma
Allam A; Elsabahy M; El Badry M; Eleraky NE
International Journal of Pharmaceutics 2021; 598: 120380 (IGR: 22-1)
90541 Nanoemulsion as a feasible and biocompatible carrier for ocular delivery of travoprost: Improved pharmacokinetic/pharmacodynamic properties
Ismail A; Nasr M; Sammour O
International Journal of Pharmaceutics 2020; 583: 119402 (IGR: 21-3)
82367 Chitosan/hydroxyethyl cellulose inserts for sustained-release of dorzolamide for glaucoma treatment: In vitro and in vivo evaluation
Franca JR; Foureaux G; Fuscaldi LL; Ribeiro TG; Castilho RO; Yoshida MI; Cardoso VN; Fernandes SOA; Cronemberger S; Nogueira JC; Ferreira AJ; Faraco AAG
International Journal of Pharmaceutics 2019; 570: 118662 (IGR: 20-4)
